PTAB Knocks Out 2 Eli Lilly Cialis Patents In AIA Reviews
The Patent Trial and Appeal Board on Wednesday said two of an Eli Lilly & Co. subsidiary's patents which cover both the erectile dysfunction drug Cialis and pulmonary arterial hypertension drug...To view the full article, register now.
Already a subscriber? Click here to view full article